Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Viad Corp (NY: VVI )

37.42 -0.02 (-0.05%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viad Corp

< Previous 1 2 3 4 Next >
Viad Corp Schedules Second Quarter 2023 Earnings Call
From Viad Corp
Via Business Wire
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
Viad: Q1 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
Via Benzinga
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
3 Promising Small-Company Stocks to Buy for a Profitable Second Half
These three under-the-radar small-company stock picks have big potential but also carry above-above average risk. 
Via InvestorPlace
12 Industrials Stocks Moving In Friday's Intraday Session
Via Benzinga
Viad Corp Reports Results for the 2023 First Quarter
From Viad Corp
Via Business Wire
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 286 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 127 companies set new 52-week lows. 
Via Benzinga
Viad Corp Schedules First Quarter 2023 Earnings Call
From Viad Corp
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 469 companies hit new 52-week lows. 
Via Benzinga
Viad Corp Announces Participation in Upcoming Conference
From Viad Corp
Via Business Wire
Viad Corp Reports Results for the 2022 Fourth Quarter and Full Year
From Viad Corp
Via Business Wire
Viad Corp Schedules Fourth Quarter and Full Year 2022 Earnings Call
From Viad Corp
Via Business Wire
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
Viad Corp Completes Sale of Non-Core Business Unit
From Viad Corp
Via Business Wire
Viad Corp Announces Participation in Upcoming Investor Events
From Viad Corp
Via Business Wire
Viad Corp Reports Results for the 2022 Third Quarter
From Viad Corp
Via Business Wire
Viad Corp Schedules Third Quarter 2022 Earnings Call
From Viad Corp
Via Business Wire
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
Trade Desk Stock Sees Improved Relative Strength Rating
Trade Desk stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 64 to 72. 
Via Investor's Business Daily
Viad Corp Provides Statement on Health of Pursuit President
From Viad Corp
Via Business Wire
Viad Corp Reports Results for the 2022 Second Quarter
From Viad Corp
Via Business Wire
Viad Corp Schedules Second Quarter 2022 Earnings Call
From Viad
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Upgrades 
Via Benzinga
Viad Corp Reports Results for the 2022 First Quarter
From Viad Corp
Via Business Wire
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.